OPPENHEIMER & CO INC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is TNXP and the CUSIP is 890260201. A total of 37 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q3 2016. The put-call ratio across all filers is 16.09 and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2016$34,000
-35.8%
73,500
-2.6%
0.00%
-50.0%
Q3 2016$53,000
-41.8%
75,500
+65.9%
0.00%
-33.3%
Q2 2016$91,000
+15.2%
45,500
+38.7%
0.00%
+50.0%
Q1 2016$79,000
-66.7%
32,800
+6.5%
0.00%
-71.4%
Q4 2015$237,000
+119.4%
30,800
+51.7%
0.01%
+133.3%
Q3 2015$108,00020,3000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2016
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,547,248$3,729,0000.20%
Broadfin Capital, LLC 825,986$1,991,0000.19%
PURA VIDA INVESTMENTS, LLC 159,877$385,0000.18%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,315,551$3,170,0000.14%
FT Options LLC 50,600$122,0000.13%
Lombard Odier Asset Management (USA) Corp 231,974$559,0000.08%
SABBY MANAGEMENT, LLC 385,248$928,0000.05%
Integre Asset Management, LLC 57,501$139,0000.04%
BLUESTEIN R H & CO LLC 185,975$448,0000.03%
Alambic Investment Management, L.P. 33,880$82,0000.03%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders